Finance Minister Jaitley Suffering From Kidney-Related Ailment
Finance Minister Arun Jaitley is suffering from a kidney ailment and may have to undergo a possible transplant.
Jaitley, 65, has skipped office since Monday and even missed the oath of taking office after being re-elected to the Rajya Sabha. He was taken to All India Institute of Medical Sciences in New Delhi for diagnostic tests, sources close to the minister and doctors said.
The minister, who cancelled his scheduled visit to London to attend the India-UK Economic and Financial Dialogue, confirmed his illness in a tweet.
I am being treated for kidney related problems & certain infections that I have contracted. I am therefore currently working from controlled environment at home. The future course of my treatment would be determined by the doctors treating me.
April 5, 2018A source at AIIMS said that the minister is likely to undergo kidney transplant and formalities for a donor kidney have been completed. Depending on doctors' advice, Jaitley may be admitted to the Cardio-Neuro Tower at AIIMS. The centre is housed in a separate building and is equipped with state-of-the-art equipment.
He is likely to be operated by nephrologist Sandeep Guleria from Apollo Hospitals. He is the brother of AIIMS director Randeep Guleria, who is a family friend of Jaitley.
The minister, however, has not yet been hospitalised but has been advised to avoid going out in public for fear of catching infection. Sources said Jaitley's present condition may be a fallout of the bariatric surgery he had undergone soon after the Bharatiya Janata Party came to power in 2014.
He underwent the surgery to treat weight gain that he suffered because of a long-standing diabetic condition. That surgery was first performed at Max Hospital, but he then had to be shifted to AIIMS because of complications. The minister, who suffers from chronic diabetes, had heart surgery several years ago.
Though he has not been attending office since Monday, he is clearing files from his residence, sources said.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
